Form 4: Neuronetics EVP, CFO and Treasurer Stephen Furlong Sells Shares
SEC Form 4
Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., sold a total of 200,000 shares of common stock in two transactions on May 12 and May 13, 2025.
Summary
- On May 12, 2025, Stephen Furlong sold 193,460 shares of Neuronetics, Inc. common stock at a weighted average price of $4.27 per share.
- The prices for these shares ranged from $4.46 to $4.15.
- On May 13, 2025, Furlong sold an additional 6,540 shares at a weighted average price of $4.16 per share, with prices ranging from $4.17 to $4.15.
- Following these transactions, Furlong directly owns 410,053 shares of Neuronetics common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of stock sales by an executive, which doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It's common for executives to periodically sell shares for personal financial management.
Stakeholder Impact
- The sale of shares by a high-ranking executive could potentially create uncertainty among shareholders, although the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding.
Key Dates
| Date | Description |
|---|---|
| 05/12/2025 | Stephen Furlong sold 193,460 shares of common stock. |
| 05/13/2025 | Stephen Furlong sold 6,540 shares of common stock. |
| 05/14/2025 | Date of signature for the Form 4 filing. |
Keywords
Neuronetics, STIM, Stephen Furlong, stock sale, Form 4, insider trading, EVP, CFO, Treasurer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.